Can Cosentyx Alter Live Vaccine Protection?
Yes, Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, weakens the immune response to live vaccines. Its prescribing information advises against live vaccines during treatment and recommends avoiding them for at least 4-6 weeks after the last dose due to reduced antibody production and protection.[1]
What Happens If You Get a Live Vaccine on Cosentyx?
Live vaccines—like MMR, varicella (chickenpox), oral polio, yellow fever, or nasal flu spray—rely on a functional immune system to build immunity. Cosentyx suppresses IL-17, which impairs this process, potentially leading to vaccine failure (no protection) or disseminated infection from the weakened virus. Case reports show attenuated responses; one study found 50-70% lower antibody titers post-vaccination in IL-17 inhibitor users.[2][1]
Which Vaccines Are Off-Limits with Cosentyx?
Avoid these live vaccines entirely:
- Measles, mumps, rubella (MMR)
- Varicella zoster
- Rotavirus
- Oral typhoid
- Live attenuated influenza (nasal spray)
- BCG (tuberculosis)
Inactivated vaccines (e.g., flu shot, shingles recombinant like Shingrix, HPV, pneumococcal) are safe and recommended before or during treatment.[1]
| Vaccine Type | Safe on Cosentyx? | Notes |
|--------------|-------------------|--------|
| Live attenuated | No | Risk of failure or infection |
| Inactivated/killed | Yes | Full response expected |
| mRNA/recombinant (e.g., COVID-19) | Yes | No live virus |
How Long After Stopping Cosentyx Can You Get a Live Vaccine?
Wait 4-6 weeks minimum after the last dose, as secukinumab's half-life is ~27 days and IL-17 suppression lingers. Some guidelines suggest up to 3 months for full immune recovery. Pre-treatment vaccination is ideal; test titers if unsure.[1][3]
What Do Doctors Recommend for Patients on Cosentyx?
Consult your rheumatologist or dermatologist before any vaccination. They may:
- Switch to inactivated alternatives.
- Time vaccines around treatment gaps.
- Monitor titers for high-risk patients (e.g., travel to yellow fever areas).
Annual flu and COVID shots remain priorities.[3]
Cosentyx vs. Other Biologics on Vaccines
Cosentyx has less broad immunosuppression than TNF inhibitors (e.g., Humira, where live vaccines are also contraindicated but responses to inactivated ones may dip more). Unlike JAK inhibitors (Xeljanz), it spares B/T-cell counts but targets IL-17 specifically.[2]
Sources
[1]: Cosentyx Prescribing Information (Novartis)
[2]: Clinical Infectious Diseases: Immunogenicity of Vaccines in IL-17 Inhibitors (2021)
[3]: ACR Guidelines on Vaccinations in Rheumatic Diseases (2019)